Advertisement FDA approves Teva ANDA to market generic Prevacid SoluTab - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Teva ANDA to market generic Prevacid SoluTab

The US Food and Drug Administration has approved Teva Pharmaceutical Industries' abbreviated new drug application (ANDA) to market a generic version of Takeda's Prevacid (lansoprazole) SoluTab.

Teva has already executed the shipment of this product.

Lansoprazole is in a group of drugs called proton pump inhibitors. Lansoprazole decreases the amount of acid produced in the stomach.

Lansoprazole is used to treat and prevent stomach and intestinal ulcers, erosive esophagitis (damage to the esophagus from stomach acid), and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome.